News
Ali Eastburn missed her son’s rehearsal dinner after her appendix burst while traveling, an incident she claims was caused by ...
Former X CEO Linda Yaccarino said Tuesday that she has taken on a new role leading a digital health platform, less than a month after announcing her departure from Elon Musk’s social media ...
Linda Yaccarino, the former CEO of the Elon Musk-owned social media platform X, has a new leadership gig in the weight loss ...
Novo Nordisk stock was downgraded to Neutral from Buy by UBS analysts, who cited the threat posed by Eli Lilly as just one ...
1h
Benzinga on MSNHims & Hers Eyes Broader Health Push Despite Earnings Miss
Hims & Hers Health shares fell 12% in after-hours trading on Monday after the telehealth company missed second-quarter ...
Investing.com -- Hims & Hers Health (NYSE: HIMS) stock edged lower on Tuesday, extending its 10% decline following disappointing earnings, as Novo Nordisk (NYSE: NVO) announced 14 new lawsuits ...
Just a month after her exit from Musk's X, the tech executive will lead the digital platform for GLP-1 health management ...
Weight loss and diabetes drugs on the market often do not achieve long-term weight loss for patients. GLP-1 drugs target brain neurons that control ...
For older adults with type 2 diabetes, glucagon-like peptide-1 receptor agonist (GLP-1 RA) use is associated with ...
Welcome to Contract Pharma’s annual ranking of the Top 20 Pharma and Biopharma Companies, based on fiscal year 2024 ...
Former X CEO Linda Yaccarino has been named CEO of eMed Population Health, a health company that says it provides a “digital health platform for GLP-1/GIP population health management.” This refers to ...
Investors must now underwrite opportunities with a “financing risk first” mindset, says Siddhi Capital cofounder Steven Finn.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results